Safety profile of Ultravist in patients with different sexes, races and from different countries/regions

20/06/2022
07/03/2024
EU PAS number:
EUPAS47805
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

22133_EU PASS_CSP_redacted

English (835.03 KB - PDF) View document
Study results
Study results

22133_EU PAS Abstract_Redacted_V1.0_2023-03-28

English (1.07 MB - PDF) View document
Study report
Study report

22133_Study Report_Redacted_V1.0_2023-03-28

English (1.44 MB - PDF) View document
Other information
Study, other information

22133_CSR_tables_Redacted_for publication_2023-09-19

English (2.41 MB - PDF) View document